Browse Technologies
Browse Technologies
Technology Keyword Search
Search Results
Displaying: 101 - 110 of 270 Results
Selectively targeting serotonergic neuron subtypes to create precision neuro-psychiatric therapeutics
Targeting central monoamine systems, such as the brain serotonergic neural system, continues to be the strategy of choice for the treatment of psychiatric disorders including depression and schizophrenia. Selective serotonin reuptake inhibitors…
DBD
- Grant Zimmermann
Investigators
- Susan Dymecki
Targeting spiral ganglion neurons for treatment of hearing loss
Hearing loss makes interactions with the world challenging for over 30 million people in the United States. While cochlear implants and hearing aid devices can ameliorate hearing loss, they often fail to restore the function of spiral ganglion…
DBD
- Irit Ben-Chelouche
Investigators
- Lisa Goodrich
Genomic Analysis Tool Box
Cancer genomes frequently harbor high mutation rates, complex structural variations, and are characterized by genome instability. Detailed understanding of these characteristics of the cancer genome is necessary for pinpointing the cause of tumor…
DBD
- Irit Ben-Chelouche
Investigators
- Peter Park
A system for in vivo generation of protective CD8+ T lymphocytes and other cells of hematopoietic origin
Differentiated CD8+ effector T cells mediate long-term immunity and protection against infectious diseases and cancer. Naive T cells are refractory to transduction with viral vectors without extensive ex vivo manipulations. A team of researchers at…
DBD
- Irit Ben-Chelouche
Investigators
- Arlene Sharpe
- Nicholas Haining
Antibody Target and Biomarker for Oocytes and Egg Quality Profiling
Harvard researchers have identified a way to isolate and manipulate oogonial stem cells (OSCs) with greater efficacy and validity than current methods. OSCs facilitate oocyte production in the ovary and serve as a foundation for promising new…
DBD
- Grant Zimmermann
Investigators
- David Sinclair
Early-life nutrition additives to protect against inflammatory bowel disease
The Kasper lab has identified membrane glycosphingolipids from the commensal bacterium Bacteroides fragilis that reduce colonic invariant natural killer T (iNKT) cells – important contributors of inflammatory bowel disease pathogenesis. Exposure to…
DBD
- Yelena Bisharyan
Investigators
- Dennis Kasper
Microbiome reagents to treat inflammatory bowel disease and restore gut homeostasis
Reactive oxygen species (ROS) and oxidative stress are believed to cause and/or aggravate several diseases, including inflammatory diseases like inflammatory bowel disease (IBD). Antioxidants have the ability to neutralize the damaging effects of…
DBD
- Grant Zimmermann
Investigators
- Wendy Garrett
Innovative microbiome anti-oxidants to repair UV damaged skin and slow aging
Ultraviolet (UV) radiation from the sun drives accumulation of reactive oxygen species (ROS) and inflammation in the skin. UV radiation also depletes skin cells of antioxidant enzymes, including superoxide dismutase (SOD). Increased ROS and…
DBD
- Grant Zimmermann
Investigators
- Wendy Garrett
Environmentally Safe, First-in-Class Mosquito Sterilant
Dr. Flaminia Catteruccia from the Harvard T.H. Chan School of Public Health has discovered a biopesticide that is capable of sterilizing mosquitoes while being safe for human and environmental health. Spraying pesticides is a common method to…
DBD
- Grant Zimmermann
Investigators
- Flaminia Catteruccia
Novel therapies for neural regeneration
Researchers at the Flanagan lab discovered a novel therapeutic approach for stimulation of neuronal regeneration. They demonstrated that type II receptor protein tyrosine phosphatases (RPTPs) get activated by several heparan sulfate proteoglycans…
DBD
- Grant Zimmermann
Investigators
- John Flanagan
- Yingjie Shen
- Alan Tenney
- Jerry Silver